Journal PubWeight™ 25253.77‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. 1997 10.08
2 Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. 1998 9.57
3 Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. 1996 7.92
4 Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. 1990 6.34
5 Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. 1993 6.20
6 Fibroblast growth factor 21 corrects obesity in mice. 2008 5.66
7 Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. 1992 5.45
8 Organizing action of prenatally administered testosterone propionate on the tissues mediating mating behavior in the female guinea pig. 1959 5.37
9 Minireview: Cyclin D1: normal and abnormal functions. 2004 5.22
10 Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. 2004 5.20
11 Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. 2003 5.09
12 Strategies and methods for research on sex differences in brain and behavior. 2004 5.02
13 Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. 2003 4.96
14 Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. 1986 4.89
15 The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. 2006 4.81
16 Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation. 1994 4.67
17 Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. 2004 4.67
18 Regulation of Kiss1 gene expression in the brain of the female mouse. 2005 4.48
19 Minireview: the OPG/RANKL/RANK system. 2001 4.47
20 Osteoblastic cells are involved in osteoclast formation. 1988 4.37
21 Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. 2005 4.35
22 Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. 1998 4.29
23 Minireview: The adipocyte--at the crossroads of energy homeostasis, inflammation, and atherosclerosis. 2003 4.28
24 Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. 2000 4.27
25 Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. 2004 4.25
26 A role for kisspeptins in the regulation of gonadotropin secretion in the mouse. 2004 4.24
27 Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. 2006 4.22
28 Establishment of clonal strains of rat pituitary tumor cells that secrete growth hormone. 1968 4.12
29 Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. 1985 4.11
30 Environmentally persistent alkylphenolic compounds are estrogenic. 1994 4.10
31 Region-specific leptin resistance within the hypothalamus of diet-induced obese mice. 2004 4.10
32 Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society. 2012 3.98
33 Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. 2003 3.93
34 Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. 2004 3.89
35 Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. 2005 3.83
36 Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. 2003 3.83
37 The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. 2000 3.80
38 The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. 1999 3.67
39 Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. 2000 3.67
40 Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. 2003 3.59
41 Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. 2004 3.54
42 Neonatal leptin treatment reverses developmental programming. 2005 3.51
43 Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. 2004 3.50
44 Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton. 2007 3.46
45 The environmental estrogen bisphenol A stimulates prolactin release in vitro and in vivo. 1997 3.44
46 Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. 2003 3.42
47 Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. 2005 3.42
48 Elucidating the role of gonadal hormones in sexually dimorphic gene coexpression networks. 2008 3.38
49 A radioimmunoassay for rat plasma ACTH. 1971 3.35
50 Developmental and hormonally regulated messenger ribonucleic acid expression of KiSS-1 and its putative receptor, GPR54, in rat hypothalamus and potent luteinizing hormone-releasing activity of KiSS-1 peptide. 2004 3.34
Next 50